Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014

The Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014, also known as H.R. 3230, was signed into law on August 7, 2014. This bill allocated $10 billion to allow veterans facing long wait times or geographic barriers to seek care outside the Department of Veterans Affairs (VA) system. An additional $5 billion was provided to hire more VA doctors and nurses and upgrade facilities. This legislation immediately expanded the market for private healthcare providers by directing a substantial portion of veteran healthcare spending to non-VA entities. The $10 billion allocated for private care flowed directly to private hospitals, clinics, and individual practitioners through reimbursement mechanisms. Companies operating acute care hospitals, such as HCA Healthcare ($HCA) and Universal Health Services ($UHS), saw increased patient volumes and revenue opportunities. Healthcare REITs like Ventas ($VTR) and Sabra Health Care REIT ($SBRA), which own and lease medical facilities, benefited from increased utilization and potential expansion of their tenant base. Medical staffing agencies, including AMN Healthcare Services ($AMN), experienced higher demand for their services as both VA and private providers sought to expand their workforce. Diagnostic and laboratory service providers, such as LabCorp ($LH) and Quest Diagnostics ($DGX), also saw increased testing volumes. Historically, similar expansions of government-funded healthcare access have led to increased revenue for private providers. For example, the Affordable Care Act (ACA) in 2010, while different in scope, expanded insurance coverage and led to a general increase in patient volumes across the healthcare sector. Following the passage of the ACA, healthcare provider stocks saw sustained growth; for instance, HCA Healthcare ($HCA) rose approximately 25% in the year following the ACA's full implementation in 2014. The Veterans' Choice Act specifically targeted a large, underserved population with dedicated funding, creating a direct and measurable revenue stream for private healthcare companies. Specific winners from this legislation included HCA Healthcare ($HCA), Universal Health Services ($UHS), and Community Health Systems ($CYH) due to increased patient admissions and outpatient services. Medical staffing firms like AMN Healthcare Services ($AMN) and Cross Country Healthcare ($CCRN) benefited from the surge in demand for healthcare professionals. Laboratory and diagnostic companies such as LabCorp ($LH) and Quest Diagnostics ($DGX) saw higher testing volumes. Companies providing medical equipment and supplies also experienced increased demand. The legislation did not create direct losers among private companies, but rather shifted a portion of the VA's internal patient load to external providers, effectively expanding the overall healthcare market for veterans. The immediate impact of the bill was the establishment of the Veterans Choice Program, which allowed eligible veterans to receive care from non-VA providers. This program was fully implemented in late 2014 and early 2015, with funding flowing to private providers as veterans utilized their new options. The program continued until it was replaced by the VA MISSION Act in 2018, which further streamlined and expanded community care options for veterans, indicating a sustained legislative commitment to leveraging private sector healthcare.